Feature

Generalizations of a generalist — common themes among systemic therapies for common cancers


 

Oncology, along with the rest of medicine, is becoming increasingly subspecialized. Early leaders in the development of medical oncology trained and practiced as generalists, but that generation has been replaced by the current generation of academic oncologists who start specialization early on, often while still in fellowship. The advantages of being able to concentrate on just one area of oncology, or even just one disease, are obvious in terms of the ability to gain expertise and to advance research. As a result, most of the current literature is written by subspecialists.

Click on the PDF icon at the top of this introduction to read the full article.

Recommended Reading

FDA approves aprepitant for 12- to 17-year-olds
MDedge Hematology and Oncology
FDA approves antiemesis drug rolapitant
MDedge Hematology and Oncology
New online tool helps estimate ‘true’ drug cost
MDedge Hematology and Oncology
Hunger hormone mimic anamorelin treats cachexia in NSCLC
MDedge Hematology and Oncology
HIT risk rises with obesity
MDedge Hematology and Oncology
ESC: Heart failure risk climbs early in childhood cancer survivors
MDedge Hematology and Oncology
New assay may be a game changer in invasive candidiasis
MDedge Hematology and Oncology
Changing oncology compliance standards: step 1 in re-valuing clinician workload for value-based cancer care
MDedge Hematology and Oncology
A qualitative exploration of supports and unmet needs of diverse young women with breast cancer
MDedge Hematology and Oncology
Effects of a self-care education program on quality of life of patients with gastric cancer after gastrectomy
MDedge Hematology and Oncology